Sefi Rosenfeld
Director - Pre-clinical & Early Clinical Development Nasus Pharma
Seminars
Thursday 4th February 2027
Generating Meaningful Preclinical Data for Powder-Based Intranasal Products: Opportunities, Challenges, & Lessons Learned
2:00 pm
- Explore the unique challenges associated with evaluating powder-based intranasal products in preclinical studies, including administration techniques, dose accuracy, and reproducibility across animal models
- Understand the strengths and limitations of commonly used preclinical approaches for assessing safety, pharmacokinetics, deposition, and product performance when developing nasal powders
- Review practical strategies developers are using to generate more relevant preclinical data and improve confidence when progressing powder-based products toward clinical development
